We compared the survival of medically and surgically treated coronary artery disease patients in subgroups of patients to determine those most or least likely to benefit from surgery after an average of 5.5 years of follow-up. Cox's regression model for survival analysis was used in conjunction with data from all patients to estimate and test for the significance of the effects of surgery on survival in subgroups of patients, defined by one or more of the following variables: number of stenotic vessels (. 70%), ejection fraction, age, heart murmur, diuretic therapy, ventricular arrhythmia on resting ECG, left main coronary artery stenosis > 50%, previous myocardial infarction, cardiomegaly, congestive heart failure, unstable angina, and functional class. The Cox model adjusts for differences between medical and surgical patients in variables shown to be predictive of survival. A statistically beneficial effect of surgery on survival was seen in patients with twoor three-vessel disease, ejection fraction > 30%, age 48 years, no heart murmur, no diuretic therapy, no ventricular arrhythmia on resting ECG, left main coronary artery stenosis < 50%, no cardiomegaly, and no congestive heart failure. The converse subgroups defined by these variables did not show a significant beneficial effect from surgery. However, patient subgroups defined by presence or absence of prior myocardial infarction or unstable angina and New York Heart Association functional class I-II vs III-IV all showed beneficial effects from surgery.
SUMMARY We compared the survival of medically and surgically treated coronary artery disease patients in subgroups of patients to determine those most or least likely to benefit from surgery after an average of 5.5 years of follow-up. Cox's regression model for survival analysis was used in conjunction with data from all patients to estimate and test for the significance of the effects of surgery on survival in subgroups of patients, defined by one or more of the following variables: number of stenotic vessels (. 70%), ejection fraction, age, heart murmur, diuretic therapy, ventricular arrhythmia on resting ECG, left main coronary artery stenosis > 50%, previous myocardial infarction, cardiomegaly, congestive heart failure, unstable angina, and functional class. The Cox model adjusts for differences between medical and surgical patients in variables shown to be predictive of survival. A statistically beneficial effect of surgery on survival was seen in patients with twoor three-vessel disease, ejection fraction > 30%, age 48 years, no heart murmur, no diuretic therapy, no ventricular arrhythmia on resting ECG, left main coronary artery stenosis < 50%, no cardiomegaly, and no congestive heart failure. The converse subgroups defined by these variables did not show a significant beneficial effect from surgery. However, patient subgroups defined by presence or absence of prior myocardial infarction or unstable angina and New York Heart Association functional class I-II vs III-IV all showed beneficial effects from surgery.
COMPARISONS of the survival of nonrandomized medically and surgically treated coronary artery disease patients in Seattle Heart Watch1 2 have indicated a beneficial effect of surgery, primarily among patients with two-vessel disease (stenoses . 70%). In the initial report,' survival was compared in patients grouped only on the number of stenotic (> 70%) vessels and ejection fraction, whereas in a later report,2 comparisons were made after adjustment for differences between medical and surgical cohorts in seven covariates identified as predictive of survival in these cohorts. 3 Surgery had a statistically significant beneficial effect in all patients combined and, in the only attempt to analyze subgroups, in patients with two-vessel disease.2 In this report, we compared survival in subgroups of medically and surgically treated patients to determine if the beneficial effect of surgery on survival is uniform in all patients, or if certain subgroups can be identified in which the effect of surgery is greatest or in which surgery might have a deleterious effect on survival.
Methods
The arteriography registry of Seattle Heart Watch, a community-wide registry of 2616 patients enrolled during 1969-1974 from all of the laboratories per-forming coronary arteriography in Seattle and with a current average follow-up after catheterization of 5.5 years, has been described.3 In that report, seven variables most predictive of survival in the medical and surgical cohorts of the registry were identified: ejection fraction, ventricular arrhythmia on the resting ECG, age, heart murmur on auscultation, stenosis of left main coronary artery, number of stenotic (. 70%) vessels and use of diuretics. This report is based on the analysis of data for the subset of 1534 patients in the registry with complete data on these seven variables and with at least one major vessel with stenosis . 70% (1158 of 1870 surgically treated patients and 375 of 746 medically treated patients).
Estimates and tests of the effects of surgery on survival in subgroups of patients were made by the use of Cox's proportional hazards regression model for survival data. 4 7 Use of this regression model allows estimation of the effects of surgery and simultaneous adjustment for differences between medical and surgical patients in the seven covariates predictive of survival. Once estimated in a subgroup, the effect of surgery can be used to express the relative risk of dying for a medical patient as compared with a surgical patient with identical values for the seven covariates. The test of significance of the effect of surgery and its associated relative risk is given by the ratio of the surgical effect to its standard error, which follows a standard normal distribution. A chi-square test for homogeneity of surgical effects across subgroups also was used to determine if a model with separate surgical effects in subgroups fit the data better than a model with one overall surgical effect. A more detailed explanation of the statistical model used in the analysis is given in the Appendix.
The subgroups considered here were based on categories of thze seven previously identified covariates VOL 63, No 3, MARCH 1981 and on five other characteristics thought by us to be of most interest: history of myocardial infarction, presence of cardiomegaly, history of congestive heart failure, presence of unstable angina and functional class. Further analyses were performed estimating the effects of surgery separately in subgroups defined by combinations of age and number of stenotic vessels, congestive heart failure and age, congestive heart failure and number of stenotic vessels, number of stenotic vessels and ejection fraction, and congestive heart failure and ejection fraction. These combinations were based on several factors. First, subgrouping by age and history of congestive heart failure produced the greatest discrepancy in surgical effects when considered alone (except for cardiomegaly, which was similar in effect to history of congestive heart failure). Second, the number of stenotic vessels is the most commonly used method of classifying coronary disease patients. Third, ejection fraction is probably the most important prognostic variable in coronary disease patients, and, when previously used in conjunction with the number of stenotic vessels in the initial report from Seattle Heart Watch,' had suggested possible differential effects.
Results
The relative risks and p values based on estimates and tests for the effects of surgical therapy in subgroups of patients, defined by single variables, are given in table 1 for the 12 variables considered. The overall test for the effect of surgery was significant, even after adjustment for differences in the seven covariates (p = 0.0008), and the risk of dying was 1.75 times higher for medical patients than for surgical patients with the same values for the seven covariates. Patients who seemed to benefit most from surgery were those with twoor three-vessel disease, those with normal (. 51%) to moderately impaired (31-50%) ejection fraction, those older than age 48 years, those without heart murmur, not on diuretic therapy, without ventricular arrhythmias, with less than 50% stenosis of the left main coronary artery, with no history of congestive heart failure, or no indication of cardiomegaly (table 1). Patients who had a history of myocardial infarction seemed to benefit more from surgery than those who had not had a myocardial infarction, although the effect of surgery was significant in both groups. Similarly, the effect of sur- 538 CI RCU LATION gery was greater for patients without unstable angina than for those with it, and was greater for those in New York Heart Association functional classes I and II than for those in classes III and IV, although it is significant in all those groups. Further attempts to define subgroups in which the effects of surgery differ were based on the use of combination of variables (tables 2-6). There is a clear, consistent pattern that reinforces and further refines the patterns shown in table 1. In table 2, the effect of surgery, while adjusting for the seven previously identified covariates, is estimated in each of nine subgroups defined by age and the number of vessels with stenosis 70%. The effect of surgery was not significant in any age group for one-vessel disease, and even indicates a higher risk in the surgically treated patients for those with one-vessel disease younger than age 48 years. Surgery has a significant beneficial effect in patients with twoor three-vessel disease who are older than age 48 years. Table 3 shows subgroups defined by age and history of congestive heart failure. The effects of surgery on survival indicate a nonsignificant adverse effect in patients younger than age 48 years who have a history of congestive heart failure, little effect in patients who had a history of congestive heart failure older than age Abbreviation: CHF = congestive heart failure. 48 years and in those younger than age 48 years who had no history of heart failure, and a highly significant beneficial effect among those older than age 48 years who had no history of heart failure. Table 4 gives the comparison of surgical effects in subgroups defined by history of congestive heart failure and the number of vessels with > 70% stenosis. As in tables 2 and 3, the bivariate result is the intersection of the univariate results, in that only in the subgroups with twoor three-vessel disease and no history of congestive heart failure was the beneficial effect of surgery significantly different from zero. The least indication of a beneficial effect of surgery was found in patients with three-vessel disease and a history of congestive heart failure, with a relative risk of 1.01.
The subgroups formed by combinations of ejection fraction and number of diseased vessels are given in table 5. The subgrouping based on ejection fraction alone (table 1) indicated an almost significant (p = 0.09) beneficial effect in patients with ejection fraction < 30%. The analysis in table 5 indicates a nonuniform effect of surgery in this subgroup, ranging from an almost significant (p = 0.11) adverse effect in patients with one-vessel disease, to an almost significant (p = 0.10) beneficial effect in those with three-vessel disease. The strongest beneficial effects of surgery were found in subgroups formed by the com-binations of ejection fraction and number of stenotic vessels for which the surgical effects had been strongest when those variables were used alone: twoand three-vessel disease with normal (> 50%) or moderately abnormal ejection fraction (31-50%). Table 6 gives results for subgroups formed by ejection fraction and history of congestive heart failure. The combinations of the best categories for each variable considered alone, namely ejection fraction less than 30% and no history of congestive heart failure, again defined the subgroups in which surgery had a highly significant beneficial effect on survival.
Each of the 17 analyses in tables 1-6 in which surgical effects were estimated separately in subgroups also included a chi-square test (not given) for homogeneity of surgical effects. A significant chisquare indicates a lack of homogeneity, or differential surgical effects across the subgroups. None of the analyses produced a significant chi-square test for homogeneity, although the analysis in table 1, based on history of congestive heart failure, came closest (p = 0.085).
Discussion
In this paper, we attempted to further refine results from Seattle Heart Watch that indicated a beneficial effect of coronary artery surgery on overall survival CI RCULATION 540 and in patients with two-vessel disease. We attempted in this analysis to adjust for differences in baseline characteristics that result from nonrandomized treatment allocation that may bias comparisons of medical and surgical cohorts. We used Cox's regression model for survival data to adjust for differences in seven covariates predictive of survival while evaluating the effects of surgery in subgroups of patients.
The results for subgroups must be interpreted with care, because at first glance they seem somewhat contradictory. First, in no case is the test for homogeneity significant. A narrow interpretation of this result would be that the overall effect of surgery is not significantly different from the effect of surgery in any subgroups. However, further examination of the p values in tables 1-6 suggests that such an interpretation would not be wise, as most variables define one or more subgroups in which the effect of surgery is significantly different from zero, along with one or more other subgroups in which the effect of surgery is not significantly different from zero, even though the effects may not differ from each other enough for the test of homogeneity to be significant. Probably the wisest use of this type of exploratory analysis is to look for patterns in the various subgroups that suggest a profile of patient characteristics likely to indicate a potentially beneficial (or nonbeneficial) effect of surgery, and to refine that profile by analyzing subgroups of patients defined by combinations of these variables.
The results confirm and expand our earlier findings from the Seattle Heart Watch. Initial analyses,' which attempted to adjust for differences between medical and surgical cohorts only with respect to ejection fraction and the number of vessels with . 70% stenosis, indicated a significant beneficial effect of surgery in patients with two-vessel disease and ejection fraction greater than 30%, a beneficial effect that was not statistically significant in patients with three-vessel disease and ejection fraction of 31-50%, and similar survival in medical and surgical patients with onevessel disease. Subsequent analyses,2 which adjusted for differences between the two cohorts with respect to the seven variables most predictive of survival, indicated an overall significant beneficial effect of surgery and, in the only attempt to examine the effect of surgery in subgroups, showed that beneficial effect to be primarily in patients with two-vessel disease. Because the effect of surgery on survival is not likely to be uniform over all categories of coronary patients, the analyses presented here were done to identify subgroups of patients in which there is a clear beneficial effect of surgery and those in which the effect of surgery on survival is of borderline significance or even deleterious. The results indicate that the coronary patient most likely to benefit by enhanced survival after surgery is older than 48 years, has twoor threevessel disease with ejection fraction greater than 30%, and has no history of congestive heart failure. Related characteristics that also indicated that surgery enhanced survival were absence of heart murmur, no ventricular arrhythmias on the resting ECG, no car-infarction, and left main coronary artery stenosis less than 50%.
Certain of these characteristics are contrary to intuition or results of other studies, and deserve further comment. One unexpected result was the significant effect of surgery observed in those with less than 50% stenosis of the left main coronary artery, and not in those with 50% or greater stenosis of the left main coronary artery. Other studies, notably the Veteran's Administration (VA) Cooperative Study,8 have shown significantly increased survival among surgical patients with left main coronary artery stenosis of 50% or greater, leading to the general practice of recommending coronary bypass surgery for patients with significant left main disease and graftable distal vessels. The results here show a slight edge for survival of surgical patients over medical patients with 50% or greater stenosis of the left main coronary artery, but this difference was not statistically significant, perhaps because of small numbers and chance occurrence. In examining several small groups of patients with left main coronary disease, occasionally one would expect to see a group with significantly higher survival than average, and this group of only 17 medically treated patients from the Seattle Heart Watch with known values for the seven covariates used in the analysis may be just such an anomaly. The 30-month survival for medically treated patients with left main coronary artery disease in the VA Cooperative Study was approximately 68%, whereas it was 82% for this small group of medically treatedpatients. However, survival for surgical patients entered into Seattle Heart Watch with 50% or greater stenosis of the left main coronary artery was comparable to that in the VA study. Given the small number of medically treated patients in this study, perhaps the results of other studies showing improved survival with surgical therapy of left main coronary artery disease should remain the basis for therapeutic decision.
The significant effect of surgery in patients with two-and three-vessel disease is somewhat different from previous reports from the Seattle Heart Watch, which indicated a significant surgical effect only in patients with two-vessel disease.1 2 The more recent report indicated better survival in surgical patients than in medical patients with three-vessel disease, but the improved survival was not statistically significant. Two factors affected the significance of the improved survival in surgical patients with three-vessel disease: an additional 2 years of follow-up and the use of the entire medical cohort to fit Cox's regression model and estimate survival among those with three-vessel disease. Previous analyses were based only on the very small subgroup of patients with three-vessel disease treated medically, who seem to have unusually good survival.
Another unexpected result was the effect of subgrouping on the basis of age. We suggested previously' that the potential for improved prognosis with surgical therapy in patients with two-vessel disease and no marked impairment of left ventricular function might justify "prophylactic" surgery, especially in the younger patients. The current analysis indicated that 541 diomegaly, no use of diuretics, a previous myocardial VOL 63, No 3, MARCH 1981 younger patients have less improvement in survival from surgery. ("Younger" is arbitrarily defined here as age younger than 48 years, corresponding to 1 standard deviation below the mean age of 52 years, and is not intended to imply a precisely defined cutoff age.)
The results of the bivariate analyses in which age was included (tables 2 and 3) and the survival curves in figures 1-6, which show some of the effects tested in tables 2 and 3, can be grouped into three categories: those which show little or no beneficial effect of surgery, those which show a significant beneficial effect of surgery, and those in which the conclusion is unclear. In patients younger than 48 years of age with either one-vessel disease or a history of congestive heart failure, survival is actually higher among the medical patients, although the differences in survival between medical and surgical patients are not statistically significant ( figs. 1 and 2) . The adverse effects on survival are at least partially due to operative mortality, and it may take several years of follow-up for any beneficial effect of surgery on survival, if present in these groups, to overcome the initial operative risk. Lower operative mortality, as is likely to exist today, would tend to make survival among medical and surgical patients in these groups very similar, as the survival curves in figures 1 and 2 differ by a fairly constant amount approximately equal to the additional early (operative) risk in the surgical group. In patients younger than 48 years of age with no history of congestive heart failure ( fig. 3) , the survival experiences of medical and surgical patients are similar. An even lower operative mortality rate would probably not 0 (7) ( 
randomized series to correct for baseline differences (n=56) known to occur as a result of treatment assignment9 (n=337) can only correct for known or measured variables. Possibly, some or all of the differences in survival could be explained by the maldistribution of an unmeasured variable. However, the degree of baseline 
543
VOL 63, No 3, MARCH 1981 Cooperative Study required 6 months of stable angina;1' patients with unstable angina were apparently excluded. Forty percent of our patients had unstable angina, with no difference between medical and surgical cohorts. This may be a very important difference and may explain the unexpectedly good survival rate in the medically treated patients in the VA Study. The multivariate analyses of prognostic variables in medically treated coronary disease patients by Harris and colleagues12 showed that the presence of progressive angina (not available in our data) was one of the most important noninvasive predictors of survival. A second important difference is that the VA study used 50% diameter reduction as the definition of a significant stenosis, whereas we used 70%. Thus, the VA study probably included patients with less severe disease, making treatment differences more difficult to demonstrate.
In contrast to the VA study, our data are consistent with the small randomized study by Kloster et al.,'
which showed a significant reduction in terminating events (death, myocardial infarction, unstable angina) in surgically treated patients with three-vessel disease and the larger randomized European Coronary Surgery Study,14 which showed a better survival rate in surgically treated patients with three-vessel disease. A comment on the statistical problem of multiple comparisons is appropriate. One might argue that, given the number of tests performed for so many different subgroupings in this analysis, a small number of the tests could be expected to be significant by chance alone. Therefore, any conclusion that surgery has a beneficial effect in only a small number of these subgroups could be a spurious result of multiple comparisons. This is the kind of erroneous conclusion due to chance or maldistribution of baseline characteristics that Lee et al.15 demonstrated could occur in their simulated randomization of medically treated patients in the Duke data bank. Reports on the Duke University series of medically and surgically treated patients had, in fact, identified one subset of patients in which survival of surgical patients was significantly higher than that of medical patients,'" but this significant difference was not sustained in a subsequent analysis that included more patients and longer follow-up.'7 The main difference between those analyses and ours is that an overall test comparing survival of medically and surgically treated patients (adjusting for differences in baseline characteristics using Cox's model) preceded this analysis,2 and indicated a significant beneficial effect of surgery on survival. Given a significant overall surgical effect, it is then appropriate to look for subgroups in which the surgical effect might be more pronounced, or even absent. Even if a conservative technique, such as the Bonferroni inequality,'8 is used to adjust for the multiple comparisons (which would require that the p values for the effects of surgery in subgroups be multiplied by the number of subgroups considered), in several subgroups surgery would still be significant. Therefore, the conclusion of a significant surgical effect is not in question; whether the effect is uniform over subgroups is. Although the analysis indicated that there was not enough statistical evidence to reject the hypothesis of a uniform beneficial surgical effect, that could be the result of small sample sizes in some subgroups. Nevertheless, general categories of patients were identified in which the effect of surgery was clearly beneficial, i.e., older patients who had multivessel disease and no evidence of advanced left ventricular dysfunction. Conversely, surgery in younger patients with one-vessel disease appeared to have a deleterious effect on survival, if it had any effect at all. This type of descriptive information giving a spectrum of effects is undoubtedly useful in interpreting the significance of the effect of surgery, even considering the multiple comparisons problem.
